David M. Smadja
Inserm(FR)Université Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Européen Georges-Pompidou(FR)Paris Cardiovascular Research Center(FR)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Venous Thromboembolism Diagnosis and Management, COVID-19 Clinical Research Studies, Pulmonary Hypertension Research and Treatments, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism(2015)270 cited
- → Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients(2020)262 cited
- → Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications(2013)236 cited
- → COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects(2021)201 cited
- → Circulating Endothelial Cells(2009)153 cited